"The new journal on Recent Patents on Anti-Cancer Drug Discovery is an important patent journal in the field of Anti-Cancer Drug Discovery, which should provide research scientists in the field with recent developments in various frontier areas. The journal is strongly recommended to the scientific community."
Robert Huber Nobel Laureate
"Recent Patents on Anti-Cancer Drug Discovery" is a very useful journal of considerable value to oncologist and researchers in biomedical fields."
Andrew V. Schally The Nobel Prize in Medicine for 1977
"Recent Patents on Anti-Cancer Drug Discovery a new journal with important information usually not immediately available to the busy laboratory scientist. Well worth a subscription."
Roger Guillemin Nobel Prize for Physiology or Medicine 1977
"Recent Patents on Anti-Cancer Drug Discovery is an important review journal in the field of anti-cancer drug research. The journal is highly recommended to all scientists active in the field of anticancer drug research and molecular oncology."
Prof. Gennaro Ciliberto Scientific Director of IRCCS Istituto Nazionale Tumori, "G. Pascale" Napoli, Italy
Zhe-Sheng (Jason) Chen Institute for Biotechnology College of Pharmacy and Health Sciences St. John's University New York, NY (USA)
Dr. Chen obtained a doctorate (Ph.D.) in Pharmacology from the Kagoshima University, Japan. He also holds an MD degree from Guangdong Medical and Pharmaceutical College and a Master's degree in Toxicology from Sun Yat-Sen University, China. Currently, Dr. Chen is a Professor at St. John’s University College of Pharmacy and Health Sciences. He is also a director of the Institute for Biotechnology at St. John’s University. He has published more than 270 scientific publications. Besides, he is the founding Editor in Chief of the Journal of Cancer Research Updates, an Editor-in-Chief of the Journal of New Developments in Chemistry and an editor of the African Journal of Pharmacy and Pharmacology. He is also an editorial board member of 26 journals and a reviewer of more than 240 peer-reviewed journals.